2008 May – 2010 Dec

Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccine African Malaria Network Trust (AMANET), Tanzania, University of Bamako, Mali | Mahamadou S. Sissoko | Africa, Western, Mali

Similar Posts

  • 2019 Mar – 2023 Feb | $7.64M

    Clinical evaluation of AntimalarialS tri-therapy with AtovAquone-Proguanil for treatment of uncomplicated malaria in African children (ASAAP) European & Developing Countries Clinical Trials Partnership (EDCTP), Kwame Nkrumah University of Science and Technology, Kumasi, Ghana | Oumou Maiga-Ascofare | Gabon, Benin, Burkina Faso, Guinea, Mali

  • Home: TMA – 2019 – Clinical Research and Product Development Fellowships

    EDCTP-Clinical Research and Product Development Fellow: Dr Amadou Hamidou Togo, MD, PhD, Université des Sciences Techniques et Technologiques de Bamako(USTTB), Faculty of Pharmacy (FAPH), Malaria Research and Training Center (MRTC) Grant Agreement number: TMA2019IF-2867 Grant Title: TMA2019 IF [ TOGO] Call for proposals: TMA2019 IF [ TOGO] The purpose of this Call for Proposals is to support researchers and members…

  • 2016 Dec – 2022 Dec | 1 subproject

    Proactive Community Case Management and Child Survival: A Cluster-Randomized Controlled Trial Child Relief International Foundation, Grand Challenges Canada, Johnson & Johnson Foundation, United States Agency for International Development (USAID), University of California San Francisco (UCSF), USA, Malaria Research and Training Center (MRTC), University of Bamako, Mali | Kassoum Kayentao, Nancy S. Padian | Mali

  • DELGEME

    The Developing Excellence in Leadership and Genetics Training for Malaria Elimination in sub-Saharan Africa (DELGEME) is a training programme sponsored by the Wellcome Trust Developing Excellence in Leadership, Training and Science Africa (DELTAS Africa) initiative in partnership with the Department of International Development (DFID) and the Alliance for Accelerating Excellence in Science in Africa (AESA). …

  • 2019 Mar – 2024 Feb | $7.09M

    Efficacy and Safety of a newly registered Artemisinin-Based Combination (Pyronaridine-Artesunate -PYRAMAX®) for the treatment of uncomplicated malaria in African pregnant women (PYRAPREG) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Kassoum Kayentao | Dem. Rep. Congo, Mozambique, Burkina Faso, Gambia, Mali

Leave a Reply

Your email address will not be published. Required fields are marked *